Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 3247  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 :: Next article
 :: Previous article 
 :: Table of Contents
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  Article in PDF (24 KB)
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  Abstract
 ::  Introduction
 ::  Methods
 ::  Results
 ::  Discussion
 ::  Acknowledgment
 ::  References
 ::  Article Tables

 Article Access Statistics
    PDF Downloaded209    
    Comments [Add]    
    Cited by others 4    

Recommend this journal


Year : 1992  |  Volume : 38  |  Issue : 4  |  Page : 183-5

Relevance of plasma fibrinogen estimation in obstetric complications.

Dept of Gynaecology and Obstetrics, Seth GS Medical College, Parel, Bombay, Maharashtra.

Correspondence Address:
H Parasnis
Dept of Gynaecology and Obstetrics, Seth GS Medical College, Parel, Bombay, Maharashtra.

Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 0001307590

Rights and PermissionsRights and Permissions

 :: Abstract 

We present a study of fibrinogen levels in 133 patients who were prone to develop disseminated intravascular coagulation as a result of an underlying complication of pregnancy such as abruptio placentae, pregnancy-induced hypertension, missed abortion, septic abortion, intrauterine fetal death, vesicular mole and amniotic fluid embolism. A high incidence of hypofibrinogenemia was found in cases of abruptio placentae (43.9%) and pregnancy-induced hypertension (25%). Hypofibrinogenemia occurred in 10% cases of intrauterine fetal death within 4 weeks of fetal demise. The use of this simple investigation makes possible the diagnosis of hemostatic failure and also helps to guide replacement therapy during the fibrinopenic state. There were 4 maternal deaths and 12 perinatal losses in this study.

Keywords: Abruptio Placentae, complications,epidemiology,Disseminated Intravascular Coagulation, blood,complications,epidemiology,Female, Fetal Death, epidemiology,Fibrinogen, analysis,Human, Hypertension, complications,epidemiology,Incidence, Pregnancy, Pregnancy Complications, Cardiovascular, epidemiology,Pregnancy Complications, Hematologic, blood,epidemiology,Pregnancy Outcome, Prospective Studies, Risk Factors,

How to cite this article:
Parasnis H, Raje B, Hinduja I N. Relevance of plasma fibrinogen estimation in obstetric complications. J Postgrad Med 1992;38:183

How to cite this URL:
Parasnis H, Raje B, Hinduja I N. Relevance of plasma fibrinogen estimation in obstetric complications. J Postgrad Med [serial online] 1992 [cited 2020 Jan 23];38:183. Available from:

  ::   Introduction Top

Hemostatic failure, as an end result of various complications of pregnancy, is an important cause of maternal mortality in India[1],[2]. The occurrence of disseminated intravascular coagulation (DIC) in various obstetric complications such as abruptio placentae, intrauterine fetal death (lUFD), missed abortion, septic abortion, pregnancy induced hypertension (PIH), and amniotic fluid embolism is known[3],[4],[5],[6],[7],[8],[9],[10],[11],[12].

The diagnosis of this dreaded complication usually requires complicated laboratory tests, which may not be feasible at all centres. [13] Estimation of plasma fibrinogen, on the other hand, is a simple and accurate method of diagnosing hemostatic failure.

The present communication deals with our study of fibrinogen levels in various obstetric complications and its correlation with the outcome of pregnancy.

  ::   Methods Top

A prospective study was carried out at the University hospital in Bombay where on an average, 4,000 deliveries are conducted every year. During a period of two years (1988-1989), 133 cases presenting with various obstetric complications such as abruptio placentae, PIH, IUFD, missed abortion, septic abortion and amniotic fluid embolism were studied. The mean age of the patients was 24.3 years and the mean parity was 2.4.

Plasma fibrinogen was estimated routinely at the time of admission in these patients. In cases of lUFD, serial fibrinogen estimations were required. Thus, a total of 167 estimations were performed in 133 patients. Clotting time was measured in some cases as part of the routine clinical work-up, on clinical suspicion of DIC, coagulation profile was done.

Plasma fibrinogen was estimated by King's microjeldahl precipitation method, which involved isolation of fibrin from plasma, acid digestion, messlerisation and comparison with a standard[1],[4].

Plasma fibrinogen levels were then correlated with the occurrence of clinical manifestations of DIC, the line of therapy followed, and the maternal and perinatal mortalities.

  ::   Results Top

Hypofibrinogenemia (Plasma fibrinogen < 300 mg%) was found in 38 of the 133 cases thus giving an incidence of 28.6%. The hypofibrinogenemia was mild (plasma fibrinogen 150-300 mg%) in 30 of these 38 patients (78.9%) and severe (plasma fibrinogen < 150 mg%)[15],[16],[17] in the remaining 8 patients (21.1 %).

The incidence of hypofibrinogenemia in various obstetric complications and the correlation with maternal and perinatal mortalities is shown in [Table - 1]. The mean fibrinogen level in cases of abruptio placentae was found to be 209 mg%.

Hypofibrinogenemia occurred within 4 weeks of fetal demise in 3 of the 30 cases with IUFD (10%) and occurred after 4 weeks of fetal death in 6 of the 30 cases (20%). Of the 15 patients with a missed abortion of less than 12 weeks gestational age, only 2 (13.3%) developed hypofibrinogenemia, whereas of the 2 patients with missed abortion of more than 12 weeks gestational age; developed severe hypofibrinogenemia. All the 8 patients of severe hypofibrinogenemia developed clinical manifestations while none of the patients with normal fibrinogen levels developed DIC.

In the cases with mild hypofibrinogenemia, blood transfusions alone sufficed to stabilise the clotting system of the patient clinically. However, in the cases with severe hypofibrinogenemia, fresh frozen plasma and cryoprecipitate were required in addition to blood transfusions to correct the clotting deficiency.

  ::   Discussion Top

A common terminal event in pregnancy induced complications is the occurrence of DIC[3],[4],[5],[6],[7],[8],[9],[10],[11],[12], which is responsible for maternal mortality[1],[2].

After the onset of clinical manifestations, the diagnosis of DIC is simplified but the treatment becomes difficult. Thus, it is important to diagnose DIC at its subclinicai stage so that early therapeutic measures can be instituted. The estimation of plasma fibrinogen is helpful not only in the early diagnosis of hemostatic failure but also to puide replacement therapy during the fibrinopenic state[13].

In patients with abruptio placentae, the incidence of hypofibrinogenemia was found to be 43.9% in this study, which is significantly higher than the incidence of 25-38% found in another study[17]. The incidence of severe hypofibrinogenemia in abruptio was found to be 9.7% in this study which compares favourably with the range of 4 - 10% quoted by Sher[18],[19]. Only 5 patients (13%) with abruptio placentae in this study later developed clinical manifestations of DIC.

In abruptio placentae, hypofibrinogenemia may be associated with increased levels of fibrin degradation products, which are known to inhibit myometrial contractifity[19],[20],[21]. Thus, its detection warns the physician of the possibility of postpartum haemorrhage.

A good correlation has been reported between plasma fibrinogen levels and the amount of blood loss in a case of abruptio placentae. The presenting fibrinogen level of < 150 mg% indicates a loss of 2,000 ml of blood. The fibrinogen level helps to calculate the amount of blood required to stabilise a patient's hemodynamic condition. Particularly in concealed haemorrhage, a vast underestimation of blood loss frequently occurs and when the vital signs deteriorate it may be difficult or impossible to catch up[16].

We found that the mean fibrinogen level in cases of abruptio placentae was 209 mg%, which compares favourably with the figure of 170.8 mg% found by 13hattacharya and Malkani[22]. However, this is stli significantly lower than the normal range (300-600 mg%) for pregnancy[15].

In the women with IUM, hypofibrinogenemia occurred within 4 weeks of fetal death in 10% and after 4 weeks of fetal death in 20% of the cases thus giving a total incidence of 30%. Earlier, Jimenez and Pritchard[23] reported that hypofibrinogenemia is unlikely to occur within a period of 5 weeks after fetal demise. They also found that only one third of the patients with a dead fetus retained in utero for more than 5 weeks had fibrinogen levels < 1 50 mg%[23]. However, findings of our study are supported by Hatch et al[24] who have shown that the time interval between fetal death and uterine evacuation does not influence the development of coagulopathy.

Furthermore, the balance of evidence indicates primary fibrinogen consumption as the cause of coagulopathy in IUM. From a practical point of view, one should therefore measure the fibrinogen level rather than rely upon other tests as an indirect measure of DIC[25]. Also, the clotting system must be evaluated before initiating therapeutic measures for termination of pregnancy, even if less than 4 weeks have elapsed since fetal demise. Similar precautions are indicated for cases of missed abortion where the underlying pathology responsible for hypofibrinogenemia is similar to that of IUFD. This is especially important in view of the high incidence (17.7%) of hypofibrinogenemia in missed abortion observed in this study.

Although, hypofibrinogenemia occurred in only 1 case each, of vesicular mole (11.1%) and septic abortion (6.7%), it is advisable to order a coagulation screen in all patients of vesicular mole and septic abortion. A similar suggestion was made earlier in a study by Talbert et al[26].

The incidence of hypofibrinogenemia in cases of pregnancy, induced hypertension was found to be as high as 25%. Most other studies have found fibrinogen levels to be normal in cases of PIH[27],[28],[29]. An interesting observation was that in 3 of 15 patients (20%) with normal plasma fibrinogen levels, clotting time was prolonged. The decreased hepatic blood supply in cases of P1H may bring about a qualitative alteration in the fibrinogen molecule and hence the prolonged clotting time in spite of normal plasma fibrinogen levels. This has been termed as ‘dysfibrinogenemia’[30].

In conclusion, estimation of plasma fibrinogen is a simple method of evaluating obstetric patients prone to hemostatic failure. It's importance lies in the fact that it helps to diagnose a fibrinopenic stage when effective therapeutic measures can completely reverse the condition. We recommend that this estimation be part of the routine work-up of all patients with obstetric complications such as abruptio placentae, pregnancy induced hypertension, missed abortion, septic abortion, vesicular mole, intrauterine fetal death and amniotic fluid emolism.

  ::   Acknowledgment Top

We are grateful to the Dean, Seth GS Medical College and King Edward Memorial Hospital for allowing us to publish this data.

 :: References Top

1. Panat SP, Mehendale SS. Maternal mortality - Review of 6 years. J Obstet Gynecol India 1987; 37:527-529.  Back to cited text no. 1    
2.Sinha J. A 5 year study of maternal mortality: analysis of its causative factors (1976-1980) J Obstet Gynecol India 1986; 36:404-406.  Back to cited text no. 2    
3.Chung AF, Merkatz IR. Survival following amniotic fluid embolism with early heparinisation. Obstet Gynecol 1973; 42: 890-814.  Back to cited text no. 3    
4.Dixon RD. Disseminated intravascuiar coagulation: a paradox of thrombosis and haemorrhage - significance. Obstet Gynecol Surv 1973; 28:385-395.  Back to cited text no. 4    
5.Graeff H, Ernst E, Boeaz JA. Evaluation of hypercoagulability in septic abortion. Flemostasis 1976; 5:285-294.  Back to cited text no. 5    
6.Gregory MG, Clayton EM Jr. Amniotic fluid embolism. Obstet Gynecol 1973; 42:236-244.  Back to cited text no. 6    
7.Gralnick HR. Intravascular coagulation and differential diagnosis and conditioning mechanism. Postgrad Med 1977; 62:68-81.  Back to cited text no. 7    
8.Lester EP, Roth DG. Disseminated intravascular coagulation in pregnancy. J Reprod Med 1977; 19:223-232.  Back to cited text no. 8    
9.Letsky E. Hemostasis and haemorrhage. In: de Sweit M Ed. Medical Disorders in Obstetric Practice. Oxford: Blackwell Scientific Publ; 1984; 70-94.  Back to cited text no. 9    
10.Ratnoff OD, Vosburgh GJ. Observations on the clotting defect in amniotic fluid embolism. N Engl J Med 1952; 247:970-973  Back to cited text no. 10    
11.Resnik R, Swartz WH, Plumer MH. Amniotic fluid embolism with survival. Obstet Gynecol 1976; 47:295-298.  Back to cited text no. 11    
12.Talbert LM, Blatt PM. Disseminated intravascular coagulation in obstetrics. Clin Obstet Gynecol 1979; 22:889-900.  Back to cited text no. 12    
13.Romero R. The management of acquired hemostatic failure during pregnancy. In: Berkowitz RL, editor. Critical Care of the Obstetric Patient. New York: Churchill Livingstone; 1983, pp 219-284.  Back to cited text no. 13    
14.Hog TB, Osiwer VN, Summerson WH. Practical Physiological Chemistry, 13th ed. McGraw Hill Book Co; 1954, pp 603.  Back to cited text no. 14    
15.Brown JCM. Coagulation disorders in pregnancy and labour. In: Postgraduate Obstetics and Gynecology, 4th ed. London: Butterworths Co Ltd; 1973, pp 581-585.  Back to cited text no. 15    
16.Knight AB, Arias F. Third trimester bleeding. In: Arias F Ed. High Risk Pregnancy and Delivery. St Louis: CV Mosby; 1984; 278-300.  Back to cited text no. 16    
17.Pritchard JA, Brekken AL. Clinical and laboratory studies on severe abruptio placentae. Am J Obstet Gynecol 1967; 97:681-695.  Back to cited text no. 17    
18.Sher G. A rational basis for the management of abruptio placenta. J Reprod Med 1978; 21:123-129.  Back to cited text no. 18    
19.Sher G. Pathogenesis and management of uterine inertia complicating abruptio placentae with consumption coagulopathy. Am J Obstet Gynecol 1977; 129: 164-170.  Back to cited text no. 19    
20.Basu HK. Fibrinolysis and abruptio placentae. J Obstet Gynecol (Br Commonwealth) 1969; 76:481-496.  Back to cited text no. 20    
21.Pritchard JA. Hematological problems associated with delivery, placental abruption, retained dead fetus and amniotic fluid embolism. Clin Hematol 1973; 2: 563-586.  Back to cited text no. 21    
22.Bhattacharya AR, Malkani PK. Study of fibrinogen in pregnancy with special reference to hypofibrinogenemia. J Obstet Gynecol India 1961; 11:734-736.  Back to cited text no. 22    
23.Jimenez JM, Pritchard JA. Pathogenesis and treatment of coagulation defects resulting from fetal death. Obstet Gynecol 1968; 32: 449-459.  Back to cited text no. 23    
24.Hatch RL, Barke JI, Barke MW. Coagulopathy associated with dilatation and evacuation for intrauterine fetal death. Obstet Gynecol 1985; 66:463-467.  Back to cited text no. 24    
25.Romero R, Copel JA, Hobbins JC. Intrauterine fetal demise and hemostatic failure: the fetal death syndrome. In: Pitkin RM, Scott JR, Weiner CP Eds. Clinical Obstetrics and Gynecology. Vol 28, No I. Hagerstown: Harper and Row; 1985, pp 24-31.  Back to cited text no. 25    
26.Talbert LM, Easterline WE, Flowers CE, Graham JB. Acquired coagulation defects of pregnancy including a case of patient with hydadidiform mole. Obstet Gynecol 1961; 18:69-76.  Back to cited text no. 26    
27.Galton M, Merritt K, Beller FK. Coagulation studies of the peripheral circulation of patients with toxemia of pregnancy: a study for evaluation of disseminated intravascular coagulation and toxemia. J Reprod Med 1971; 6:89-91.  Back to cited text no. 27    
28.Pritchard JA, Cunningham FG, Mason RA. Coagulation changes in edampsia - their frequency and pathogenesis. Am J Obstet Gynecol 1976; 124:855-859.  Back to cited text no. 28    
29.Weinstein L. Syndrome of hemolysis, elevated liver enzymes and lowered platelet count - a severe consequency of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142:159-167.  Back to cited text no. 29    
30.Anderson GD, Sibai BM. Hypertension in pregnancy. In: Gabbe S, Niebyl J, Simpson JL, editors. Obstetrics - Normal and Problem Pregnancies. New York: Churchill Livingstone; 1986; 819-863.   Back to cited text no. 30    


[Table - 1]

This article has been cited by
1 The effect of experimental Bothrops jararaca envenomation on pregnant mice
Spadacci-Morena DD, de Tomy SC, Sano-Martins IS, et al.
TOXICON. 2006; 47 (2): 196-207
2 Fibrinogen substitution in the treatment of bleeding due to lack of fibrinogen
Ingerslev, J., Sørensen, B.
Ugeskrift for Laeger. 2005; 167(25-31): 2759-2761
3 Successful obstetrical management of 110-day intertwin delivery interval without cerclage: Counseling and conservative management approach to extreme asynchronous twin birth
Ghulmiyyah, L.M., Wehbe, S.A., Schwartz, S.A., Sills, E.S.
BMC Pregnancy and Childbirth. 2004; 4: 23
4 Pregnancy-induced hypertension and insulin resistance: evidence for a connection
Innes KE, Wimsatt JH


Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow